Cargando…

Advances in the management of squamous cell carcinoma of the head and neck

Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide. The main risk factors for cancers of the oral cavity, larynx, oropharynx, and hypopharynx are alcohol and tobacco use. In addition, the human papillomavirus (HPV) is an established cause of oropharyngeal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machiels, Jean-Pascal, Lambrecht, Maarten, Hanin, François-Xavier, Duprez, Thierry, Gregoire, Vincent, Schmitz, Sandra, Hamoir, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047945/ https://www.ncbi.nlm.nih.gov/pubmed/24991421 http://dx.doi.org/10.12703/P6-44

Ejemplares similares

Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
por: Schmitz, Sandra, et al.
Publicado: (2015)

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report
por: Collette, Fanny, et al.
Publicado: (2020)

2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck
por: Mignion, Lionel, et al.
Publicado: (2018)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck
por: van Caloen, Gabrielle, et al.
Publicado: (2021)

Comparable Accuracy of Quantitative and Visual Analyses of [(18)F]FDG PET/CT for the Detection of Lymph Node Metastases from Head and Neck Squamous Cell Carcinoma
por: d’Abadie, Philippe, et al.
Publicado: (2023)

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma
por: Hamoir, Marc, et al.
Publicado: (2018)

Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
por: Schmitz, Sandra, et al.
Publicado: (2015)

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
por: Seront, Emmanuel, et al.
Publicado: (2019)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
por: Machiels, Jean-Pascal H, et al.
Publicado: (2014)

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group
por: Klinghammer, Konrad, et al.
Publicado: (2022)

Editorial: Advances in the Involvement of Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma
por: Lechien, Jerome R., et al.
Publicado: (2022)

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy
por: Machiels, Jean-Pascal, et al.
Publicado: (2016)

Advancements in the Management of HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zeitlin, Ross, et al.
Publicado: (2015)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
por: Phillips, T. J., et al.
Publicado: (2019)

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
por: Magnes, Teresa, et al.
Publicado: (2021)

Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Han-Qi, et al.
Publicado: (2023)

The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
por: Gong, Yingying, et al.
Publicado: (2023)

Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Zheng, Shuwen, et al.
Publicado: (2023)

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma
por: Fayette, Jérôme, et al.
Publicado: (2015)

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019)

Docetaxel in the treatment of squamous cell carcinoma of the head and neck
por: Rapidis, Alexander, et al.
Publicado: (2008)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck
por: Vincent, Aurora G., et al.
Publicado: (2020)

Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borcoman, Edith, et al.
Publicado: (2021)

Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma
por: Rahman, Sadia, et al.
Publicado: (2019)

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck
por: Posner, M R, et al.
Publicado: (2003)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
por: Van Waes, Carter, et al.
Publicado: (2017)

Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Thai Hoa, Nguyen Thi, et al.
Publicado: (2020)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review)
por: Yang, Mengyuan, et al.
Publicado: (2023)

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary
por: Abu-Shama, Yazan, et al.
Publicado: (2021)

Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region()()()
por: Melo, Giulianno Molina de, et al.
Publicado: (2021)

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)
por: Pai, Sara I., et al.
Publicado: (2019)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1ii2p3gfjcbarq13e5visbf9gb